How will Australia's traditional approach to health technology assessment manage a multi-million dollar one-time injection with the 'potential' to cure and add 40, 50, 60 or even 70 years of normal life expectancy? The US could lead the way.
Do you value a lifetime benefit based on almost no evidence?
May 29, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Myrio Therapeutics partners with leading US research institutions to advance T cell immunotherapies for solid tumours
October 28, 2025 - - Australian Biotech -
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost life sciences collaboration
October 28, 2025 - - Australian Biotech -
Australians want better access to medical technology, and a clearer pathway to get there
October 28, 2025 - -
Pharmacy Guild backs expanded prescribing rights for optometrists
October 28, 2025 - - Latest News -
PYC reports strong clinical momentum and cash position ahead of key readouts
October 27, 2025 - - Australian Biotech -
Government backs new national push to close bone health testing gap for women
October 27, 2025 - - Latest News -
Leadership change at PolyNovo as long-time Chair steps down
October 27, 2025 - - Australian Biotech
